Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer
BackgroundImmune checkpoint inhibition therapy has been achieved significant success in the treatment of non-small cell lung cancer (NSCLC). However, the role of soluble immune checkpoint- related proteins in NSCLC remains obscure.MethodsWe evaluated the circulating levels of 14 immune checkpoint-re...
Main Authors: | Qinchuan Wang, Yue He, Wanlu Li, Xiaohang Xu, Qingfeng Hu, Zilong Bian, Andi Xu, Huakang Tu, Ming Wu, Xifeng Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.887916/full |
Similar Items
-
Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins
by: Sai Pan, et al.
Published: (2023-05-01) -
Combining Classic and Novel Neutrophil-Related Biomarkers to Identify Non-Small-Cell Lung Cancer
by: Yunzhao Ren, et al.
Published: (2024-01-01) -
Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma
by: Jianfei Zhu, et al.
Published: (2023-03-01) -
Pulmonary adenocarcinoma in situ with morule - like components: A surgical case report
by: Mitsuteru Yosida, et al.
Published: (2024-01-01) -
Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
by: Linbin Hua, et al.
Published: (2023-05-01)